Power Law company profile

Immatics biotechnologies

Biotech & Life Sciences · Tübingen, Germany · Founded 2000 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$970M

Market cap · Apr/2026

Revenue

$53M

Latest reported FY

Investors

17 investors on Immatics biotechnologies's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 6 investors entered at this stage

Series B+ 11 investors entered at this stage

Swisscom Ventures

DH Capital

KfW

dievini Hopp Biotech holding

Global footprint

Where Immatics biotechnologies has talent and traffic

AI talent share

2.2% of workforce is AI talent
(14 of 627 staff)

Core AI60.96%

Other AI81.28%

Non-AI workforce61397.77%

Web traffic by country

48K monthly visits
across markets

🇺🇸 United States85%

🇩🇪 Germany9.8%

🇮🇳 India2.1%

🇬🇧 United Kingdom2.1%

🇨🇦 Canada0.8%

Top 5 markets shown

See Immatics biotechnologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo